These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30012492)

  • 1. Harnessing albumin as a carrier for cancer therapies.
    Hoogenboezem EN; Duvall CL
    Adv Drug Deliv Rev; 2018 May; 130():73-89. PubMed ID: 30012492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
    Kratz F
    J Control Release; 2008 Dec; 132(3):171-83. PubMed ID: 18582981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.
    Abedin F; Anwar MR; Asmatulu R; Yang SY
    J Biomater Appl; 2015 Jul; 30(1):38-49. PubMed ID: 25638169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter.
    Wang F; Yang K; Wang Z; Ma Y; Gutkind JS; Hida N; Niu G; Tian J
    Nanoscale; 2016 Feb; 8(7):3991-4000. PubMed ID: 26818100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery.
    Spada A; Emami J; Tuszynski JA; Lavasanifar A
    Mol Pharm; 2021 May; 18(5):1862-1894. PubMed ID: 33787270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review.
    Van de Sande L; Cosyns S; Willaert W; Ceelen W
    Drug Deliv; 2020 Dec; 27(1):40-53. PubMed ID: 31858848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advancement on albumin nanoparticles in treating lung carcinoma.
    Sristi ; Fatima M; Sheikh A; Almalki WH; Talegaonkar S; Dubey SK; Amin MCIM; Sahebkar A; Kesharwani P
    J Drug Target; 2023 Jun; 31(5):486-499. PubMed ID: 37125741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicine.
    Ishima Y; Fang J; Kragh-Hansen U; Yin H; Liao L; Katayama N; Watanabe H; Kai T; Suenaga A; Maeda H; Otagiri M; Maruyama T
    J Pharm Sci; 2014 Jul; 103(7):2184-2188. PubMed ID: 24846171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin Nanocarriers, γ- Irradiated Crosslinked, Combined with Therapeutic Drugs for Cancer Therapy>.
    Siri M; Achilli E; Grasselli M; Del V Alonso S
    Curr Pharm Des; 2017; 23(35):5272-5282. PubMed ID: 28619004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.
    Wagner S; Rothweiler F; Anhorn MG; Sauer D; Riemann I; Weiss EC; Katsen-Globa A; Michaelis M; Cinatl J; Schwartz D; Kreuter J; von Briesen H; Langer K
    Biomaterials; 2010 Mar; 31(8):2388-98. PubMed ID: 20031203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-Based Nanodevices as Drug Carriers.
    Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
    Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
    Qu N; Lee RJ; Sun Y; Cai G; Wang J; Wang M; Lu J; Meng Q; Teng L; Wang D; Teng L
    Int J Nanomedicine; 2016; 11():3451-9. PubMed ID: 27555767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs.
    Yu L; Hua Z; Luo X; Zhao T; Liu Y
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188655. PubMed ID: 34780933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
    Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
    Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery Strategies for Platinum-Based Chemotherapy.
    Browning RJ; Reardon PJT; Parhizkar M; Pedley RB; Edirisinghe M; Knowles JC; Stride E
    ACS Nano; 2017 Sep; 11(9):8560-8578. PubMed ID: 28829568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL.
    Li R; Yang H; Jia D; Nie Q; Cai H; Fan Q; Wan L; Li L; Lu X
    J Control Release; 2016 Apr; 228():96-106. PubMed ID: 26951928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical update of using albumin as a drug vehicle - a commentary.
    Kratz F
    J Control Release; 2014 Sep; 190():331-6. PubMed ID: 24637463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.